| Culturally Tailored Educational and Support Program to Increase Quality of Life Among Korean Breast Cancer Survivors (NCT02770469) | University of Maryland, College Park | 2014-02-01 |
| Prognostic Relevance of Biological Subtype in Breast Cancer (NCT02063906) | Samsung Medical Center | 2014-02-01 |
| Incorporation of AlloMaxTM in Breast Reconstruction Ver8-15-12 (NCT01679223) | University of Nevada, Las Vegas | 2014-02-01 |
| A Study of Trastuzumab Emtansine (Kadcyla) Plus Pertuzumab (Perjeta) Following Anthracyclines in Comparison With Trastuzumab (Herceptin) Plus Pertuzumab and a Taxane Following Anthracyclines as Adjuvant Therapy in Participants With Operable HER2-Positive Primary Breast Cancer (NCT01966471) | Hoffmann-La Roche | 2014-01-31 |
| Pertuzumab and Trastuzumab as Neoadjuvant Treatment in Patients With HER2-Positive Breast Cancer (NCT01937117) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2014-01-30 |
| Study of Insulin-like Growth Factor (IGF)-Methotrexate Conjugate in the Treatment of Advanced Tumors Expressing IGF-1R (NCT02045368) | IGF Oncology, LLC | 2014-01-28 |
| Study of the Anti-tumoral Immune Response (NCT02854644) | Centre Hospitalier Universitaire de Besancon | 2014-01-27 |
| Phase II Short-term Adjuvant Therapy and Biomarker Studies With Targeted Agents in Women With Estrogen Receptor Negative Breast Cancer (NCT01471106) | M.D. Anderson Cancer Center | 2014-01-21 |
| Partial Irradiation and Sequential vs. Concurrent Chemo Early Breast Cancer (NCT01928589) | Richard Zellars | 2014-01-16 |
| Pet Imaging as a Biomarker in Hormone Refractory postmenopausaL Women (NCT02028364) | Jules Bordet Institute | 2014-01-12 |
| Phase Ib/II Study of LY2780301 in Combination With Weekly PACLITAXEL in HER2-metastatic Breast Cancer (NCT01980277) | Institut Paoli-Calmettes | 2014-01-01 |
| Prophylaxis of Hematologic Complications With Naderin in First-Line Breast Cancer Chemotherapy (NCT07671547) | MIPO Clinic | 2014-01-01 |
| Cognitive Enhancement Program in Improving Cognitive Function in Breast Cancer Survivors (NCT02166983) | Stanford University | 2014-01-01 |
| Palbociclib in Combination With Adjuvant Endocrine Therapy for Hormone Receptor Positive, HER2 Negative Invasive Breast Cancer (NCT02040857) | Dana-Farber Cancer Institute | 2014-01-01 |
| Presurgical Treatment With Letrozole in Patients With Early-stage Breast Cancer. (NCT02010021) | Dartmouth-Hitchcock Medical Center | 2014-01-01 |
| Improving Compliance With Medical Testing Guidelines (NCT02430948) | Beth Israel Medical Center | 2014-01-01 |
| A Clinical Trial to Determine the Most Suitable Dose of OPB-111001 in Patients With Advanced Cancer (NCT02042885) | Otsuka Novel Products GmbH | 2014-01-01 |
| Bone Metastasis and Surgery in Breast Cancer (NCT02125630) | Federation of Breast Diseases Societies | 2014-01-01 |
| Standard Chemotherapy Followed by Capecitabine as Prolonged Postoperative Adjuvant Treatment for Breast Cancer (NCT02842099) | Peking Union Medical College Hospital | 2014-01-01 |
| Effect of Physical Therapy on Breast Cancer Related Lymphedema (NCT02015897) | Esbjerg Hospital - University Hospital of Southern Denmark | 2014-01-01 |
| Self-Reported Exercise Behavior and Short-Term Patient Outcomes in Women Undergoing Radiation Treatment for Operable Breast Cancer (NCT02050620) | Duke University | 2014-01-01 |
| NK Cell Infusions With Trastuzumab for Patients With HER2+ Breast and Gastric Cancer (NCT02030561) | National University Hospital, Singapore | 2014-01-01 |
| Healthy Families to Change Obesity in Public Housing Residents (NCT03111680) | University of Washington | 2014-01-01 |
| Assessment of the Decision-making Impact of the Breast Cancer Index in Recommending Extended Adjuvant Endocrine Therapy for Patients With Early Stage ER-positive Breast Cancer (NCT02057029) | Yale University | 2014-01-01 |
| Localization of Nonpalpable Breast Lesions (NCT01901991) | Rigshospitalet, Denmark | 2014-01-01 |
| Prospective Observational Study of Antitumor Activity Correlation Between Hormonal Therapy and Expression miRNA100 (NCT02950207) | Fondazione del Piemonte per l'Oncologia | 2014-01-01 |
| Behavioral Weight Loss and Exercise After Treatment (BEAT) (NCT02052115) | University of Vermont | 2014-01-01 |
| Mifepristone and Eribulin in Patients With Metastatic Triple Negative Breast Cancer or Other Specified Solid Tumors (NCT02014337) | Corcept Therapeutics | 2014-01-01 |
| Mobile Phone Multimedia Messaging Intervention for Breast Cancer Screening (NCT01972048) | University of Minnesota | 2014-01-01 |
| Study of Optimizing Neoadjuvant Regimens in Subtypes of Breast Cancer (NCT02041338) | Chinese Academy of Medical Sciences | 2014-01-01 |
| Circulating MicroRNA as Biomarker of Cardiotoxicity in Breast Cancer (NCT02065908) | West Pomeranian Cancer Center | 2014-01-01 |
| Application of Surgical Navigation System in Sentinel Lymph Node of Breast Cancer Research (NCT02084784) | Chinese Academy of Sciences | 2014-01-01 |
| Study of the ICG Distribution in the Margins of Breast Cancer After Tumorectomy (NCT02027818) | Jules Bordet Institute | 2014-01-01 |
| Ultrasound-based Breast Cancer Screening in Chinese Women (NCT02268643) | Peking Union Medical College Hospital | 2014-01-01 |
| DCE-MRI and DWI for Detection and Diagnosis of Breast Cancer (NCT02022579) | American College of Radiology Imaging Network | 2014-01-01 |
| Breast Cancer Margin Delineation Using Polarization Subtraction Imaging Technology (NCT02207179) | LumaMed | 2014-01-01 |
| The Use of Laser-Assisted Indocyanine Green Dye Angiography to Predict Mastectomy Skin Flap Viability (NCT01554267) | Stony Brook University | 2014-01-01 |
| The Effects of Indocyanine Green Angiography (IGA) on Deep Inferior Epigastric Artery Perforator (DIEP) Flap Design and Post-Operative Fat Necrosis (NCT02144961) | University of Washington | 2014-01-01 |
| X Versus Placebo as Postoperative Adjuvant Treatment for Elder Breast Cancer (NCT02838238) | Peking Union Medical College Hospital | 2014-01-01 |
| Contrast Enhanced Ultrasound and Shear Wave Elastography in Measuring Response in Patients With Breast Cancer Receiving Chemotherapy Before Surgery (NCT02067884) | University of Southern California | 2013-12-19 |
| A Phase 1 Study to Evaluate MEDI4736 in Combination With Tremelimumab (NCT01975831) | Ludwig Institute for Cancer Research | 2013-12-19 |
| Efficacy and Safety Study of Enzalutamide in Combination With Exemestane in Patients With Advanced Breast Cancer (NCT02007512) | Pfizer | 2013-12-16 |
| A Study of Pertuzumab and Trastuzumab Subcutaneous (SC) Treatment in Combination With a Taxane in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Breast Cancer (NCT02019277) | Hoffmann-La Roche | 2013-12-05 |
| Longitudinal Evaluation of Taxane Induced Neuropathy in Early Stage Breast Cancer (NCT02125019) | Ohio State University Comprehensive Cancer Center | 2013-12-04 |
| Evaluation of Continuous Positive Airway Pressure for Tumor Motion Management in Radiotherapy (NCT02324530) | Sheba Medical Center | 2013-12-01 |
| Danish Observational Study of Everolimus Plus Exemestane in Hormone Receptor (HR) Positive, Human Epidermal Growth Factor 2 (HER2) - Metastatic Breast Cancer (NCT02023359) | Novartis Healthcare A/S | 2013-12-01 |
| Exploratory Study on the Use of Pregabalin for the Treatment of Taxol Related Arthralgia-Myalgia (NCT02024568) | Assaf-Harofeh Medical Center | 2013-12-01 |
| Neoadjuvant Chemotherapy in HER2 Positive Breast Cancer, TRAIN-2 (NCT01996267) | The Netherlands Cancer Institute | 2013-12-01 |
| High Dose Vitamin D vs Standard Dose Vitamin D Study (NCT01988090) | Mothaffar Rimawi | 2013-12-01 |
| Randomized Controlled Single-blind Trial to Evaluate the Mobile Tracking of Symptoms in Ambulatory Breast Cancer Patients (NCT02004496) | University of Zurich | 2013-12-01 |
| TAILORx Tissue Bank (NCT02050750) | Cancer Trials Ireland | 2013-12-01 |
| IORT (Intra-operative Radiation Therapy) in Early Stage Breast Cancer (NCT01988870) | Shayna Showalter, MD | 2013-12-01 |
| Identification and Semi-Quantification of Ki-67 Protein Expression Status (NCT02654457) | Applied Spectral Imaging Ltd. | 2013-12-01 |
| Safety and Efficacy of YPEG-rhG-CSF in Cancer Patients Receiving Chemotherapy (NCT02005458) | Xiamen Amoytop Biotech Co., Ltd. | 2013-12-01 |
| A Study Evaluating Veliparib as a Single Agent or in Combination With Chemotherapy in Subjects With Solid Tumors (NCT02033551) | AbbVie | 2013-12-01 |
| Olive Oil for High Risk Breast Cancer Prevention in Women (NCT02068092) | The Methodist Hospital Research Institute | 2013-12-01 |
| A Phase II Trial Testing Oral Administration of Lucitanib in Patients With Fibroblast Growth Factor Receptor (FGFR)1-amplified or Non-amplified Estrogen Receptor Positive Metastatic Breast Cancer (NCT02053636) | Institut de Recherches Internationales Servier | 2013-12-01 |
| Investigational Drug in Combination With Two Chemotherapy Drugs in Women With Locally Recurrent or Metastatic Breast Cancer (NCT01349088) | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | 2013-12-01 |
| Study of the ICG Distribution in Breast Tumours or in Axillary Lymph Nodes of Patients After Neoadjuvant Therapy (NCT02032563) | Jules Bordet Institute | 2013-12-01 |
| Sentinel Node Biopsy in Breast Cancner: Omission of Axillary Clearance After Micrometastasis (NCT02049632) | Karolinska Institutet | 2013-12-01 |
| Improving Psychosocial Quality of Life in Women With Advanced Breast Cancer (NCT01811264) | Northwestern University | 2013-12-01 |
| A Study of Subcutaneous At Home Administration of Trastuzumab (Herceptin) in Participants With Human Epidermal Growth Factor Receptor 2-positive (HER2+) Early Breast Cancer (eBC) (NCT01926886) | Hoffmann-La Roche | 2013-11-19 |
| A Study of the Safety of Subcutaneously Administered Trastuzumab (Herceptin) in Participants With Early and Locally Advanced Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer (NCT01940497) | Hoffmann-La Roche | 2013-11-15 |
| A Phase 1 Study of Pegilodecakin (LY3500518) in Participants With Advanced Solid Tumors (NCT02009449) | Eli Lilly and Company | 2013-11-15 |
| Core Biopsies for Establishing a Breast Tumor Tissue Repository (NCT02250352) | University of Southern California | 2013-11-14 |
| Correlate BRCA1 Protein Expression With Response to DNA Damaging Chemotherapy (NCT01990352) | University of Arizona | 2013-11-05 |
| Combined Elastography and Color Doppler Ultrasonography for Breast Screening With Ultrasound (NCT01963624) | Seoul National University Hospital | 2013-11-01 |
| Extended Treatment in Metastatic Breast Cancer With Eribulin (NCT02769364) | Eisai Limited | 2013-11-01 |
| Metabolic Syndrome and Female Breast Cancer (NCT02282592) | Catholic University of Pelotas | 2013-11-01 |
| A Phase 1 Trial of NY-ESO-1 With GLA-SE in Patients With Unresectable or Metastatic Cancer (NCT02015416) | Immune Design, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 2013-11-01 |
| A Pilot/Phase II Study of Gamma Knife Radiosurgery for Brain Metastases Using 3Tesla MRI and Rational Dose Selection (NCT02005614) | Yale University | 2013-11-01 |
| A Study to Evaluate the Effects of Veliparib on Heart Rhythms in Patients With Solid Tumors (NCT02009631) | AbbVie | 2013-11-01 |
| A Pilot Study of Working Women and Breast Cancer (NCT01914614) | Robin Vanderpool | 2013-11-01 |
| Cryoablation of Small Breast Tumors in Early Stage Breast Cancer (NCT01992250) | Sanarus Technologies, Inc. | 2013-11-01 |
| Genomic Investigation of Unusual Responders (NCT03740503) | University Health Network, Toronto | 2013-11-01 |
| Evaluation of Magnetic Resonance Imaging (MRI) vs Molecular Breast Imaging (Tc-MBI) in Breast Cancer Patients (NCT02024074) | Emory University | 2013-11-01 |
| Effect of Chemotherapy on Pain Sensitivity and Patient-reported Symptoms (NCT01983982) | University of Michigan | 2013-11-01 |
| HumanaH - Hu3s193 in the Treatment of Advanced Breast Cancer After Hormonal Therapy (NCT01370239) | Instituto do Cancer do Estado de São Paulo | 2013-11-01 |
| Maintenance Hormone Therapy for Postmenopausal HR Positive Advanced Breast Cancer (NCT02000193) | Sun Yat-sen University | 2013-11-01 |
| Integrated Cancer Repository for Cancer Research (NCT02012699) | University of Nebraska | 2013-11-01 |
| LTX-315 in Patients With Transdermally Accessible Tumours as Monotherapy or Combination With Ipilimumab or Pembrolizumab (NCT01986426) | Lytix Biopharma AS | 2013-11-01 |
| Examining the Relationships Between Sleep, Fatigue, and Pain in Aromatase Inhibitor-treated Patients (NCT01983995) | University of Michigan | 2013-11-01 |
| Exercise to Prevent Aromatase Inhibitor Side Effects in Breast Cancer Patients (NCT01954706) | Baltimore VA Medical Center | 2013-11-01 |
| Dose-dense (Biweekly) Carboplatin Plus Paclitaxel With or Without Trastuzumab as Neoadjuvant Treatment for Breast Cancer (NCT02059876) | Guangdong Provincial People's Hospital | 2013-11-01 |
| Lifestyle, Exercise and Nutrition Study 2 (LEAN 2) (NCT02110641) | Yale University | 2013-11-01 |
| Multiplex Testing for Breast Cancer Susceptibility: A Pilot Study of Subject Preferences for Information and Responses After Testing (NCT01992471) | Memorial Sloan Kettering Cancer Center | 2013-11-01 |
| Treatment of Solid Tumors With Intratumoral Hiltonol® (Poly-ICLC) (NCT01984892) | Nina Bhardwaj | 2013-11-01 |
| Imaging With 111 Indium (111In)-Pertuzumab (PmAb) to Predict Response to Trastuzumab (TmAb) in Human Epidermal Growth Factor-2 (HER2) Positive Metastatic Breast Cancer (MBC) or Locally Advanced Breast Cancer (LABC) (NCT01805908) | Ontario Clinical Oncology Group (OCOG) | 2013-11-01 |
| Correlation Between Genetic Variants and Long-term Cardiac Effects Induced by Doxorubicin in Breast Cancer Patients (NCT02078388) | National University Hospital, Singapore | 2013-11-01 |
| Biomarkers of Fatigue Related to Adjuvant Chemotherapy for Breast Cancer (NCT02041364) | Faculdade de Medicina do ABC | 2013-11-01 |
| A Study of Palbociclib in Addition to Standard Endocrine Treatment in Hormone Receptor Positive Her2 Normal Patients With Residual Disease After Neoadjuvant Chemotherapy and Surgery (NCT01864746) | GBG Forschungs GmbH | 2013-10-30 |
| T Cell Receptor Immunotherapy Targeting NY-ESO-1 for Patients With NY-ESO-1 Expressing Cancer (NCT01967823) | National Cancer Institute (NCI) | 2013-10-24 |
| Effects of Meditation on Cognitive Function and Quality of Life (NCT02162329) | M.D. Anderson Cancer Center | 2013-10-22 |
| Study of LEE011, BYL719 and Letrozole in Advanced ER+ Breast Cancer (NCT01872260) | Novartis Pharmaceuticals | 2013-10-22 |
| Medico-economic Study of Three Strategies of Sentinel Lymph Node Analysis in Operable Breast Cancer (NCT02056886) | Institut Cancerologie de l'Ouest | 2013-10-21 |
| Vitamin D Supplementation to Correct the Vitamin D Deficiency for Breast Cancer (NCT04091178) | Institut du Cancer de Montpellier - Val d'Aurelle | 2013-10-10 |
| Effectivenes of Cyanoacrylate (Glubran 2®) in Reducing Seroma Formation in Breast Cancer Patients Post-Axillary Dissection (NCT02141373) | King Hussein Cancer Center | 2013-10-01 |
| Treatment for Joint Pains Due to Aromatase Inhibitor Therapy in Breast Cancer (NCT01612728) | Baylor Breast Care Center | 2013-10-01 |
| BBBD Followed By Methotrexate and Carboplatin With or Without Trastuzumab in Treating Women With Breast Cancer That Has Spread to the Brain (NCT00397501) | OHSU Knight Cancer Institute | 2013-10-01 |
| Effects of Vitamin D in Patients With Breast Cancer (NCT01948128) | Ottawa Hospital Research Institute | 2013-10-01 |